# Oral Iron for Erythropoietic Protoporphyrias

> **NCT02979249** · NA · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 16 (actual)

## Conditions studied

- Erythropoietic Protoporphyria
- EPP
- X-linked Protoporphyria
- XLP

## Interventions

- **DRUG:** Oral Iron

## Key facts

- **NCT ID:** NCT02979249
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2019-07-19
- **Final completion:** 2019-07-19
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-09-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02979249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02979249, "Oral Iron for Erythropoietic Protoporphyrias". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02979249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*